Skip to content
FY'25FY'24FY'23FY'22
$493.7M+0.2%$492.7M-17.0%$593.4M+1.3%$585.9M-11.5%
$168.6M+11.1%$151.8M+13.5%$133.7M+14.4%$116.9M0.0%
$23.8M+27.3%$18.7M-19.7%$23.3M-1.7%$23.7M-36.8%
$754.8M+15.5%$653.4M-15.9%$776.5M+7.3%$724M+24.0%
$285.9M-24.2%$377M+4.1%$362M+27.2%$284.6M+12.3%
-$285.9M+24.5%-$378.7M-2.7%-$368.7M-27.9%-$288.2M-13.9%
$61.2M+3.6%$59.1M+3.7%$57M+5.4%$54.1M+5.9%
$560.9M+28.0%$438.3M+116%$202.9M
-$185.1M+70.3%-$622.6M-35.5%-$459.6M-56.5%-$293.6M-74.3%
$306.7M-$40.4M
$468.9M+69.6%$276.4M-33.3%$414.5M-5.7%$439.4M+32.9%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

How much cash does West Pharmaceutical Services generate?
West Pharmaceutical Services (WST) generated $715.3M in operating cash flow over the trailing twelve months.
What is West Pharmaceutical Services's free cash flow?
After $257.3M of capital expenditures, West Pharmaceutical Services's free cash flow was $458.0M over the trailing twelve months, up 49.2% year over year.
Where does West Pharmaceutical Services's cash flow data come from?
Every line is extracted from West Pharmaceutical Services's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.